Russell Investments Group, Ltd. Adverum Biotechnologies, Inc. Transaction History

Russell Investments Group, Ltd.

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$1.5 - $2.33 $24,000 - $37,280	16,000 New	16,000 $24,000
Q2 2022 Jul 29, 2022	SELL	$0.81 - $1.34 $62,075 - $102,693	-76,637 Closed	0 $0
Q1 2022 May 05, 2022	SELL	$1.23 - $1.95 $94,341 - $149,565	-76,700 Reduced 50.02%	76,637 $100,000
Q4 2021 Jan 21, 2022	SELL	$1.74 - $2.4 $124,328 - $171,487	-71,453 Reduced 31.79%	153,337 $269,000
Q3 2021 Nov 08, 2021	SELL	$2.08 - $3.6 $1,098 - $1,900	-528 Reduced 0.23%	224,790 $487,000
Q2 2021 Aug 04, 2021	BUY	$3.36 - $10.56 $487,505 - $1.53 Million	145,091 Added 180.85%	225,318 $787,000
Q4 2020 Feb 08, 2021	SELL	$9.84 - $14.26 $370,318 - $536,660	-37,634 Reduced 31.93%	80,227 $869,000
Q3 2020 Nov 09, 2020	BUY	$10.3 - $21.64 $776,990 - $1.63 Million	75,436 Added 177.81%	117,861 $1.21 Million
Q2 2020 Aug 05, 2020	BUY	$8.53 - $25.64 $107,580 - $323,371	12,612 Added 42.3%	42,425 $883,000
Q1 2020 May 06, 2020	BUY	$7.98 - $16.32 $237,907 - $486,548	29,813 New	29,813 $291,000
Q3 2018 Oct 26, 2018	SELL	$4.5 - $7.6 $93,150 - $157,320	-20,700 Closed	0 $0
Q2 2018 Aug 08, 2018	SELL	$5.3 - $6.9 $10,600 - $13,800	-2,000 Reduced 8.81%	20,700 $110,000
Q1 2018 May 11, 2018	SELL	$3.65 - $7.95 $112,993 - $246,108	-30,957 Reduced 57.69%	22,700 $132,000
Q4 2017 Feb 06, 2018	SELL	$2.85 - $3.95 $35,163 - $48,735	-12,338 Reduced 18.7%	53,657 $193,000
Q3 2017 Nov 07, 2017	BUY	$2.45 - $3.65 $161,687 - $240,881	65,995	65,995 $241,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $681M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.